Published in November 27th, 2008
From MIT Tech Review:
“Many believe that lasers should be used not just to create wounds but to mend them too. Abraham Katzir, a physicist at Tel Aviv University, has a system that may just do the trick and is proving successful in its first human trials.
In principle, “laser-bonded” healing offers certain advantages over classic needle-and-thread [...]
continue reading.....
Published in November 26th, 2008
This, from BusinessWeek, is no surprise to those of us living in Silicon Valley.
“a November 2008 study by Robert W. Fairlie, a professor at the University of California at Santa Cruz, gives the strongest evidence to date that critics of open-immigration policies have misjudged the impact of immigrants on the U.S. economy.
Issued under the auspices [...]
continue reading.....
Published in November 26th, 2008
From Cnet news:
“Professor Kishan Dholakia and Dr. Frank Gunn-Moore–both of the University of St. Andrews in Scotland–say the “light saber” could be used routinely on cancer patients within the next five years.
The method would allow chemotherapy drugs to be pumped directly into cancer cells. The researchers believe hard-to-reach cancers such as that of the pancreas [...]
continue reading.....
Published in November 26th, 2008
From the UK’s Daily Mail:
“Scientists believe that ‘heavy water’ enriched with a rare form of hydrogen could add as much as 10 years to life.
Foods, from steak to eggs, could also be modified to allow us to eat and drink our way to a healthy old age. The idea is the brainchild of Mikhail [...]
continue reading.....
Published in November 25th, 2008
This is great news, particularly since the American population is aging and cancer tends to strike older people at higher rates.
From Reuters:
“Cancer rates have dropped for the first time in the United States and previous declines in cancer deaths are accelerating, a report released on Tuesday showed as cancer-fighting efforts produced solid results. [...]
continue reading.....
Published in November 20th, 2008
According to the Arizona Republic, “The chairman of Eli Lilly & Co. said the future of the pharmaceutical industry rests not with blockbuster drugs but with targeted therapies that work for smaller groups of people based on their biological makeup.” This is no huge surprise for those following biotech, but it is a significant [...]
continue reading.....
Published in November 20th, 2008
For the longest time, scientists haven’t had tools at their disposal to measure biological (as opposed to simple chronological) age. They finally found some doing research on worms and plan more studies as well. This is a big deal as “examining biomarkers over time would provide a scientific baseline for clinical trials of [...]
continue reading.....
Published in November 19th, 2008
From Scientific American:
“A new study shows that the cancer drugs imatinib (also known as Gleevec by Novartis) and sunitinib (Sutent, made by Pfizer) halt diabetes in mice.
A team from the University of California, San Francisco and Berkeley-based drug maker Plexxikon found that most of the mice manipulated to have Type 1 diabetes no longer had [...]
continue reading.....
Published in November 19th, 2008
From the TimesOnline:
“A woman has been given a new section of windpipe created from her own stem cells in an operation that could revolutionise surgery.
Claudia Castillo, 30, who lives in Barcelona, has become the first person to be given a whole organ tailor-made for her in laboratories across Europe.
A graft from a donor was used, [...]
continue reading.....
Published in November 14th, 2008
Japanese consumers are known to be ardent gadget lovers, but that doesn’t mean that technology development is thriving in Japan. In fact, the country has been surprisingly inhospitable to entrepreneurs, as I recently discovered when I traveled to Tokyo for the Silicon Valley Connect trip. That could change, though — especially if smart people from [...]
continue reading.....
Published in November 13th, 2008
From Bloomberg News:
“Doctors may someday slow or reverse the aging process with drugs that stimulate the body to repair itself as a result of research undertaken by Pfizer Inc.
Pfizer, the world’s largest drugmaker, will spend $100 million during the next five years to harness stem cells to treat heart disease, diabetes and vision loss common [...]
continue reading.....
Published in November 13th, 2008
This is a great article by Joe Nocera of the New York Times on the effectiveness of bringing a business mindset to disease research. He interviews Michael J. Fox and Andy Grove on how the best ways to run a foundation.
continue reading.....
Published in November 12th, 2008
According to Cnet News:
“Philips Research is out with a new intelligent camera pill that can be electronically preprogrammed to deliver targeted doses of medicine to patients with digestive disorders such as Crohn’s disease, colitis, and colon cancer. The device comes in the form of an 11 mm x 26 mm capsule that patients swallow [...]
continue reading.....
RSS 2.0
